Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network

Background: Melanomas are often easy to recognize clinically but determining whether a melanoma is in situ (MIS) or invasive is often more challenging even with the aid of dermoscopy. Recently, convolutional neural networks (CNNs) have made significant and rapid advances within dermatology image ana...

Full description

Bibliographic Details
Main Authors: Sam Polesie, Martin Gillstedt, Gustav Ahlgren, Hannah Ceder, Johan Dahlén Gyllencreutz, Julia Fougelberg, Eva Johansson Backman, Jenna Pakka, Oscar Zaar, John Paoli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.723914/full
id doaj-16164fa4e6a4407d8f4d33b440587847
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Sam Polesie
Sam Polesie
Martin Gillstedt
Martin Gillstedt
Gustav Ahlgren
Hannah Ceder
Hannah Ceder
Johan Dahlén Gyllencreutz
Julia Fougelberg
Julia Fougelberg
Eva Johansson Backman
Eva Johansson Backman
Jenna Pakka
Jenna Pakka
Oscar Zaar
Oscar Zaar
John Paoli
John Paoli
spellingShingle Sam Polesie
Sam Polesie
Martin Gillstedt
Martin Gillstedt
Gustav Ahlgren
Hannah Ceder
Hannah Ceder
Johan Dahlén Gyllencreutz
Julia Fougelberg
Julia Fougelberg
Eva Johansson Backman
Eva Johansson Backman
Jenna Pakka
Jenna Pakka
Oscar Zaar
Oscar Zaar
John Paoli
John Paoli
Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
Frontiers in Medicine
artificial intelligence
clinical decision-making
melanoma
neural networks
computer
supervised machine learning
author_facet Sam Polesie
Sam Polesie
Martin Gillstedt
Martin Gillstedt
Gustav Ahlgren
Hannah Ceder
Hannah Ceder
Johan Dahlén Gyllencreutz
Julia Fougelberg
Julia Fougelberg
Eva Johansson Backman
Eva Johansson Backman
Jenna Pakka
Jenna Pakka
Oscar Zaar
Oscar Zaar
John Paoli
John Paoli
author_sort Sam Polesie
title Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
title_short Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
title_full Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
title_fullStr Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
title_full_unstemmed Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural Network
title_sort discrimination between invasive and in situ melanomas using clinical close-up images and a de novo convolutional neural network
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2021-09-01
description Background: Melanomas are often easy to recognize clinically but determining whether a melanoma is in situ (MIS) or invasive is often more challenging even with the aid of dermoscopy. Recently, convolutional neural networks (CNNs) have made significant and rapid advances within dermatology image analysis. The aims of this investigation were to create a de novo CNN for differentiating between MIS and invasive melanomas based on clinical close-up images and to compare its performance on a test set to seven dermatologists.Methods: A retrospective study including clinical images of MIS and invasive melanomas obtained from our department during a five-year time period (2016–2020) was conducted. Overall, 1,551 images [819 MIS (52.8%) and 732 invasive melanomas (47.2%)] were available. The images were randomized into three groups: training set (n = 1,051), validation set (n = 200), and test set (n = 300). A de novo CNN model with seven convolutional layers and a single dense layer was developed.Results: The area under the curve was 0.72 for the CNN (95% CI 0.66–0.78) and 0.81 for dermatologists (95% CI 0.76–0.86) (P < 0.001). The CNN correctly classified 208 out of 300 lesions (69.3%) whereas the corresponding number for dermatologists was 216 (72.0%). When comparing the CNN performance to each individual reader, three dermatologists significantly outperformed the CNN.Conclusions: For this classification problem, the CNN was outperformed by the dermatologist. However, since the algorithm was only trained and validated on 1,251 images, future refinement and development could make it useful for dermatologists in a real-world setting.
topic artificial intelligence
clinical decision-making
melanoma
neural networks
computer
supervised machine learning
url https://www.frontiersin.org/articles/10.3389/fmed.2021.723914/full
work_keys_str_mv AT sampolesie discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT sampolesie discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT martingillstedt discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT martingillstedt discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT gustavahlgren discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT hannahceder discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT hannahceder discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT johandahlengyllencreutz discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT juliafougelberg discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT juliafougelberg discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT evajohanssonbackman discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT evajohanssonbackman discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT jennapakka discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT jennapakka discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT oscarzaar discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT oscarzaar discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT johnpaoli discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
AT johnpaoli discriminationbetweeninvasiveandinsitumelanomasusingclinicalcloseupimagesandadenovoconvolutionalneuralnetwork
_version_ 1717380107722555392
spelling doaj-16164fa4e6a4407d8f4d33b4405878472021-09-14T05:00:12ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-09-01810.3389/fmed.2021.723914723914Discrimination Between Invasive and In Situ Melanomas Using Clinical Close-Up Images and a De Novo Convolutional Neural NetworkSam Polesie0Sam Polesie1Martin Gillstedt2Martin Gillstedt3Gustav Ahlgren4Hannah Ceder5Hannah Ceder6Johan Dahlén Gyllencreutz7Julia Fougelberg8Julia Fougelberg9Eva Johansson Backman10Eva Johansson Backman11Jenna Pakka12Jenna Pakka13Oscar Zaar14Oscar Zaar15John Paoli16John Paoli17Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenDepartment of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenDepartment of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, SwedenBackground: Melanomas are often easy to recognize clinically but determining whether a melanoma is in situ (MIS) or invasive is often more challenging even with the aid of dermoscopy. Recently, convolutional neural networks (CNNs) have made significant and rapid advances within dermatology image analysis. The aims of this investigation were to create a de novo CNN for differentiating between MIS and invasive melanomas based on clinical close-up images and to compare its performance on a test set to seven dermatologists.Methods: A retrospective study including clinical images of MIS and invasive melanomas obtained from our department during a five-year time period (2016–2020) was conducted. Overall, 1,551 images [819 MIS (52.8%) and 732 invasive melanomas (47.2%)] were available. The images were randomized into three groups: training set (n = 1,051), validation set (n = 200), and test set (n = 300). A de novo CNN model with seven convolutional layers and a single dense layer was developed.Results: The area under the curve was 0.72 for the CNN (95% CI 0.66–0.78) and 0.81 for dermatologists (95% CI 0.76–0.86) (P < 0.001). The CNN correctly classified 208 out of 300 lesions (69.3%) whereas the corresponding number for dermatologists was 216 (72.0%). When comparing the CNN performance to each individual reader, three dermatologists significantly outperformed the CNN.Conclusions: For this classification problem, the CNN was outperformed by the dermatologist. However, since the algorithm was only trained and validated on 1,251 images, future refinement and development could make it useful for dermatologists in a real-world setting.https://www.frontiersin.org/articles/10.3389/fmed.2021.723914/fullartificial intelligenceclinical decision-makingmelanomaneural networkscomputersupervised machine learning